Implementing a multiple-isolator unit for centralized preparation of cytotoxic drugs in a cancer center pharmacy

Pharmacy World and Science

Volumn 21, Issue 4, 1999, Pages 177-183

  Cazin, Jean Louis ^a   Gosselin, Patricia ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

Cancer; Chemotherapy; Cytotoxics; Isolator; Pharmacy

Indexed keywords

CYTOTOXIC AGENT;

ARTICLE; CANCER CENTER; EQUIPMENT; PHARMACEUTICAL CARE; PHARMACY; QUALITY CONTROL; TECHNOLOGY; TRAINING; VALIDATION PROCESS;

ANTINEOPLASTIC AGENTS; CANCER CARE FACILITIES; EQUIPMENT AND SUPPLIES, HOSPITAL; FRANCE; HUMANS; INFUSIONS, INTRAVENOUS; OCCUPATIONAL EXPOSURE; PHARMACY SERVICE, HOSPITAL; PROTECTIVE DEVICES;

EID: 0032772846     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008731406552     Document Type: Article

References (37)

1. Simon JL, Segouin C, Bertrand D, Hospital accreditation in France. Am J Health-Syst Pharm. 1998;55:173-5.
2. Galassi A, Molloy Hubbard S, Alexander HR et al. Chemotherapy administration: practical guidelines. In: Cancer chemotherapy and biotherapy; principles and practice. 2nd ed. Chabner BA, Longo DL, eds. Philadelphia New York: Lippincott-Raven; 1996:529-51.
3. Tilleul P, Prugnaud JL, Ponsar P. Dispensation des médicaments anticancéreux 1. Etude économique d'un système décentralisé. J Pharm Clin. 1987;6:211-24.
4. Favier M, Fliche E, Bressolle F. Economic benefit of a centralized reconstitution unit of cytotoxic drugs in isolator. J Oncol Pharm Practice. 1996;2:182-5.
5. Husson C, Harnycheff F, Becker A. Centralisation des préparations de médicaments anticancéreux injectables: mise en place et bilan dans le service pharmaceutique d'un hôpital parisien. J Pharm Clin. 1989;8:153-60.
6. Augry F, Iltis A, Letellier D et al. Evaluation de l'économie réalisée au sein d'une unité centralisée de fabrication des médicaments cytotoxiques destinés à la voie parentérale. J Pharm Clin 1996;15:12-4.
7. Kinoo J, Becker A. Incidence économique des préparations de cytostatiques. Pharm Hosp Fr. 1993;103:5-14.
8. Pinguet F, Canal P, Favre G et al. Expérience de préparation centralisée des anticancéreux: conséquences économiques. J Pharm Clin. 1989;9:55-60.
9. Lunik MC, Peters BG, Wilson AL. Quality-improvement processes in an oncology pharmacy service. Am J Health-Syst Pharm. 1996;53:757-9.
10. Power LA, Anderson RW, Cortopassi R et al. Update on safe handling of hazardous drugs: the advice of experts. Am J Hasp Pharm. 1990;47:1050-60.
11. Society of Hospital Pharmacists of Australia. Practice Standards and definitions. Soc Hosp Pharm Austr. Melbourne: SHPA; 1996.
12. Davis KS, Goulding NM. Setting up a cytotoxic reconstitution service. In: The cytotoxics handbook. 2nd ed. Allwood MC, Wright P, eds. Oxford: Radcliffe Medical Press; 1993:1-7.
13. Goulding NM, Lee MG, Moore AC. Facilities. In: The cytotoxic handbook. 2nd ed. Allwood MC, Wright P, eds. Oxford: Radcliffe Medical Press;1993:9-24.
14. Allwood MC, Cass Y, Goss IJ et al. Health and safety aspects of cytotoxic services. In: The cytotoxic handbook. 2nd ed. Allwood MC, Wright P, eds. Oxford: Radcliffe Medical Press;1993:47-65.
15. Larroutourou P, Tangourdeau MC, Taggiasco N et al. Isotechnie en pharmacie hospitalière: application à la reconstitution centralisée des cytostatiques (1ère partie). Pharm Hosp.1989;98:9-15.
16. Larroutourou P, Tangourdeau MC, Taggiasco N et al. Isotechnie en pharmacie hospitalière: application à la reconstitution centralisée des cytostatiques (2 ème partie). Pharm Hosp. 1989;99:7-18.
17. Philip V, Saux MC. Bilan d'une année d'expérience d'une unité de reconstitution des médicaments anticancéreux au CHU de Bordeaux. Techn Hosp. 1992;565:47-56.
18. Roos I, Makela T. Human resource issues in cytotoxic drug dispensing. J Oncol Pharm Practice; 3:200-18.
19. Favier M, Hansel S, Bressolle F. Preparing cytotoxic agents in an isolator. Am J Health-Syst Pharm. 1993;50:2335-9.
20. Prugnaud JL, Tilleul P. Dispensation des médicaments anticancéreux 2. Etude économique et technique comparative de deux systèmes centralisés. J Pharm Clin. 1987;6:225-36.
21. Demange C, Aglat M. Préparation centralisée des cytostatiques. Expérience d'un centre hospitalier général. Pharm Hosp Fr. 1990;94:1363-75.
22. Buttars KA, Goss IJ et al. Documentation. In: The cytotoxic handbook. 2nd ed. Allwood MC, Wright P, eds. Oxford: Radcliffe Medical Press;1993:67-71.
23. Wourms P, May I. Maintenance d'un isolateur en Pharmacie hospitalière. Lyon Pharm. 1995;45:261-6.
24. Ignoffo RJ. Preventing chemotherapy errors. Am J Health-Syst Pharm. 1996;53:733.
25. Cohen MR, Anderson RW, Attilio RM et al. Preventing medication errors in cancer chemotherapy. Am J Health-Syst Pharm. 1996;53:737-46.
26. Jenkins D, Cairns C, Barber N. The quality of written inpatient prescriptions. Int J Pharm Pract. 1993;2:176-9.
27. Kohler DR, Montello MJ, Green L et al. Standardizing the expression and nomenclature of cancer treatment regimens. Am J Hosp Pharm. 1998;55:137-44.
28. Holmes BC. Administration of cancer chemotherapy agents. In: Cancer chemotherapy handbook. 2nd ed. Dorr RT, Von Hoff DD, eds. Norwalk: Appleton and Lange; 1994:57-94.
29. Boddy AV, Calvert AH. Individualized dosing of anticancer drugs. In: Principles of antineoplastic drug development and pharmacology. Schilsky RL, Milano GA, Ratain MJ, eds. New York: Marcel Dekker; 1996:435-55.
30. th ed. Bethesda: American Society of Health System Pharmacists;1996.
31. Husson MC, Becker A. Médicaments anticancéreux; de la préparation à l'administration. Optimisation. Editions Médicales Internationales; 1995.
32. Vigneron J, Cholvy-Laurelli F, Noirez V et al. Préparation et administration des traitements anticancéreux. 2nd ed. Lyon; Aguettant; 1996.
33. Barber N. What constitutes good prescribing? Br Med J. 1995;310:923-5.
34. Lunik MC, Wilson AL, Hill JJ et al. Pharmacy information systems: an outlook future goals. In: Pharmacy information systems: justifying, evaluating and implementing a system. Bethesda: American Society of Hospital Pharmacists; 1993:91-102.
35. Kaijser GP, Underberg WJM, Beijnen JH. The risks of handling cytotoxic drugs. II Recommendations for working with cytotoxic drugs. Pharm Weckbl [Sci] 1990;12:228-35.
36. American Society of Hospital Pharmacy. ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm. 1990;47:1033-49.
37. Ignoffo R, Stagg RJ. The role of the pharmacist in oncology: clinical practice and research. In: Fundamentals of cancer chemotherapy. Hellmann K, Carter SK, eds. New York: Mc Graw-Hill;1987:359-73.